ANALYSIS OF ANTIBIOTIC USE IN HOSPITALIZED PATIENTS WITH CHRONIC KIDNEY DISEASE AT A MEDICAL FACILITY IN SOUTHERN VIETNAM IN 2025

Thúy Hằng Hồ, Công Luận Trần, Hồ Thế Phương Nguyễn, Minh Chánh Hồ, Minh Thắng Hồ, Thị Ngọc Mai Nguyễn

Main Article Content

Abstract

Introduction: Chronic kidney disease (CKD) is a leading cause of death and has shown a steadily increasing mortality rate over the past two decades, affecting more than 10% of the global population. This study aims to analyze antibiotic utilization and evaluate the rationality of antibiotic therapy in the treatment of chronic kidney disease at Giồng Riềng District Medical Center, Kiên Giang Province, in 2025. Objectives: 1) To describe the pattern of antibiotic use among hospitalized patients with chronic kidney disease. 2) To evaluate the rationality of antibiotic utilization and identify factors associated with antibiotic use in hospitalized patients with chronic kidney disease. Methods: A descriptive cross-sectional study was conducted using retrospective data from 115 medical records of patients aged 18 years and older who were diagnosed with chronic kidney disease and received antibiotic treatment at a medical facility in southern Vietnam from January 1, 2025, to June 30, 2025. Results: Patients with chronic kidney disease had a mean age of 66.1 ± 14.2 years, with diabetes mellitus (27.83%) and heart failure (21.74%) being the most common comorbidities. Ceftriaxone was the most frequently used antibiotic (69.57%), and the treatment duration was predominantly between 8–14 days (55.65%). Monotherapy regimens accounted for 87.83%, while 95.65% of patients showed clinical improvement, highlighting the importance of antibiotic dose adjustment in reducing the risk of hemodialysis. Conclusions: The rate of antibiotic dose adjustment according to clinical guidelines in the treatment of chronic kidney disease remains low. Recommendations include: 1) Enhancing training programs for physicians and pharmacists on renal function assessment and dose adjustment. 2) Developing standardized protocols for antibiotic prescribing and dose modification. 3) Strengthening regular monitoring of renal function. 4) Promoting the use of monotherapy regimens when appropriate. 5) Increasing patient awareness of proper dosing and treatment adherence

Article Details

References

N. F. Aldardeer, M. M. Alshreef, E. A. Alharbi, A. K. Aljabri, M. H. Aljawadi, T. A. Almangour, et al. (2024) "Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study". Open Forum Infect Dis, 11 (3), ofae059.
2. E. Copari-Vargas, L. E. Copari-Vargas, T. L. Copari-Vargas, L. F. Domínguez-Valdez, E. Copari-Jimenez, J. G. Urquizo-Ayala (2025) "Bacteriological Profile and Antibiotic Susceptibility in Patients With Diabetic Foot Infections". Cureus, 17 (4), e82809.
3. J. Doshi, Y. P. Ngoc, T. T. Ma, L. T. Duong, V. T. T. Pham, V. G. Vu, et al. (2025) "The effect of antimicrobial stewardship interventions upon antimicrobial consumption and appropriateness in Vietnamese district hospitals: a cluster randomised trial". Lancet Reg Health West Pac, 60, 101620.
4. Kovesdy C. P. (2022) "Epidemiology of chronic kidney disease: an update 2022". Kidney Int Suppl (2011), 12 (1), 7-11.
5. National Institute of Diabetes and Digestive and Kidney Diseases (2023). "What is Kidney Failure?". National Insututes of Health,
6. T. T. Nguyen, T. X. Nguyen, T. T. H. Nguyen, T. N. Nguyen, H. T. T. Nguyen, H. T. T. Nguyen, et al. (2022) "Symptom Burden among Hospitalised Older Patients with Heart Failure in Hanoi, Vietnam". Int J Environ Res Public Health, 19 (20)
7. T. T. N. Nguyen, S. Y. Liang, C. Y. Liu, C. H. Chien (2022) "Self-care self-efficacy and depression associated with quality of life among patients undergoing hemodialysis in Vietnam". PLoS One, 17 (6), e0270100.
8. J. A. Roberts, M. H. Abdul-Aziz, J. Lipman, J. W. Mouton, A. A. Vinks, T. W. Felton, et al. (2014) "Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions". Lancet Infect Dis, 14 (6), 498-509.